Compare · EKSO vs LRCX
EKSO vs LRCX
Side-by-side comparison of Ekso Bionics Holdings Inc. (EKSO) and Lam Research Corporation (LRCX): market cap, price performance, sector, and recent activity on the wire.
Summary
- EKSO operates in Industrials, while LRCX operates in Technology - the two are in different parts of the market.
- LRCX is the larger of the two at $429.83B, about 10222.5x EKSO ($42.0M).
- Over the past year, EKSO is up 157.8% and LRCX is up 311.0% - LRCX leads by 153.1 points.
- EKSO has been more active in the news (16 items in the past 4 weeks vs 6 for LRCX).
- LRCX has more recent analyst coverage (25 ratings vs 0 for EKSO).
- Company
- Ekso Bionics Holdings Inc.
- Lam Research Corporation
- Price
- $11.37-1.52%
- $343.85+2.76%
- Market cap
- $42.0M
- $429.83B
- 1M return
- +22.26%
- +32.99%
- 1Y return
- +157.82%
- +310.96%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1984
- News (4w)
- 16
- 6
- Recent ratings
- 0
- 25
Ekso Bionics Holdings Inc.
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock Healthcare Product GmbH. The company was founded in 2005 and is headquartered in Richmond, California.
Lam Research Corporation
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
Latest EKSO
- Amendment: Ekso Bionics Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Director Cummins Wes was granted 200,000 shares (SEC Form 4)
- Director Miller Douglas S was granted 200,000 shares (SEC Form 4)
- Director Benson Ella G. was granted 200,000 shares (SEC Form 4)
- Director Nottenburg Richard N was granted 200,000 shares (SEC Form 4)
- Chief Financial Officer Wong Jerome was granted 40,000 shares, increasing direct ownership by 161% to 64,771 units (SEC Form 4)
- Director Davis Scott G. was granted 109,357 shares, increasing direct ownership by 139% to 188,134 units (SEC Form 4)
- Director Clancy William M was granted 200,000 shares (SEC Form 4)
- SEC Form 3 filed by Ekso Bionics Holdings Inc.
- SEC Form 3 filed by Ekso Bionics Holdings Inc.
Latest LRCX
- Senior Vice President Fernandes Neil J sold $2,371,226 worth of shares (7,659 units at $309.60) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 58,470 units (SEC Form 4)
- SEC Form SD filed by Lam Research Corporation
- Lam Research Corporation Declares Quarterly Dividend
- Lam Research upgraded by Morgan Stanley with a new price target
- SEC Form 144 filed by Lam Research Corporation
- Lam Research Corporation Announces Participation at Upcoming Conferences
- Seaport Research Partners initiated coverage on Lam Research with a new price target
- Senior Vice President Fernandes Neil J sold $4,635,894 worth of shares (18,170 units at $255.14) as part of a pre-agreed trading plan, decreasing direct ownership by 22% to 66,129 units (SEC Form 4)
- Chief Legal Officer Harter Ava sold $1,554,547 worth of shares (6,010 units at $258.66) and exercised 6,010 shares at a strike of $77.04 (SEC Form 4)
- SEC Form 10-Q filed by Lam Research Corporation